Drug intelligence / Profile preview

amalian SF 24

Development stage
Unknown
Lead developer
S&V Technologies
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Intradermal
01

Overview

amalian SF 24 is a monophasic, fully hydrated hyaluronic acid dermal filler designed for the correction of medium to very deep wrinkles and folds, facial volume augmentation, modeling of facial contours (including nose bridge and jawline), cheek volumization, hand rejuvenation, and scar correction (such as acne scars). It is injected into the middle to deep dermis. The product uses ultra-pure hyaluronic acid obtained via biofermentation (sodium hyaluronate) with excellent biocompatibility and flow properties. The effect typically lasts between nine to twelve months. It is fully degradable by hyaluronidase if needed. Amalian fillers are free from animal components and do not require allergy testing prior to use. Developed by S&V Technologies in Germany, all products are CE-marked medical devices meeting high safety standards[1][3][5][7].

Brand names
amalian SF 24amalian SF 24 advanced
Other names
amalian SF 24 advancedamalian® SF 24 advanced

Beyond the preview

Go deeper on amalian SF 24.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amalian SF 24.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call